We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Toxin-Absorbing Nanosponges Battle Bacterial Infections

By HospiMedica International staff writers
Posted on 02 Jun 2015
Toxin-absorbing nanosponges could provide localized therapy against virulent Methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a new study.

Researchers at the University of California, San Diego (UCSD; USA) and Fudan University (Shanghai, China) developed the unihybrid nanomaterial by mixed nanosponges—nanoparticles coated in a red blood cell (RBC) membrane that absorb dangerous toxins produced by MRSA, E. coli, and other antibiotic-resistant bacteria—into a hydrogel made of water and polymers. The optimized hydrogel composition helps retain the toxin-absorbing nanosponges (masquerading as RBCs) in place, while not compromising toxin transport into the gel for neutralization.

Image: Nanosponge-hydrogel treats local bacterial infections (Image: courtesy of Weiwei Gao/UCSD).
Image: Nanosponge-hydrogel treats local bacterial infections (Image: courtesy of Weiwei Gao/UCSD).

Just one RBC membrane can be used to make thousands of polymer core nanosponges, each with a diameter of approximately 85 nanometers, i.e., 3,000 times smaller than the original RBC. The number of toxins each nanosponge could absorb depended on the toxin; in the case of MRSA, one nanosponge can absorb approximately 85 alpha-hemolysin toxins. The nanosponges have a half-life of 40 hours and eventually are metabolized, together with the sequestered toxins, in the liver.

In a murine model, MRSA infected skin lesions that were treated with the nanosponge-hydrogel were significantly smaller than those that were left untreated. The researchers also showed that two days after they were injected underneath the skin of a mouse, nearly 80% of the nanosponge-hydrogels were still found at the injection site. When the nanosponges were injected without the hydrogel, only 20% of them remained at the injection site after just two hours, with most of them diffusing to the surrounding tissues. The study was published on April 31, 2015, in Advanced Materials.

“We combined the strengths of two different materials, nanosponges and hydrogels, to create a powerful formulation to treat local bacterial infections,” said senior author Prof. Liangfang Zhang, PhD, of the school of engineering. “Nanosponges alone are difficult to use on local tissues because they diffuse away to other parts of the body very quickly. By integrating the nanosponges into a hydrogel, we can retain them at the site of infection.”

Related Links:

University of California, San Diego
Fudan University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Portable Color Doppler Ultrasound Scanner
DCU10
New
60 SMS Sterilization Wrap
Steri-Wrap Unite

Latest Critical Care News

Spongelike Bandage with Antimicrobial Efficacy Stops Hemorrhaging and Mitigates Risk of Infection

Key Protein Offers Potential New Treatment for Systolic Heart Failure

Groundbreaking Solution Offers Continuous ICU-Level Noninvasive Hemodynamic Monitoring